or Try an Advanced Search...

    Percutaneous Coronary Intervention Stocks List

    Symbol Grade Name % Change
    NSPR C InspireMD, Inc. -0.98
    LLY F Eli Lilly and Company -0.47
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Percutaneous Coronary Intervention stocks.

    Symbol Grade Name Weight
    IHE D iShares U.S. Pharmaceutical ETF 20.67
    MEDX F Horizon Kinetics Medical ETF 15.83
    THNR F Amplify Weight Loss Drug & Treatment ETF 14.71
    OZEM F Roundhill GLP-1 & Weight Loss ETF 14.13
    XLV D SPDR Select Sector Fund - Health Care 11.9
    View all Percutaneous Coronary Intervention ETFs...
    Compare ETFs
    Compare IHE to MEDX Compare MEDX to XLV Compare THNR to OZEM

        Percutaneous Coronary Intervention Stocks Recent News

        Date Stock Title
        Nov 21 LLY Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
        Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
        Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
        Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
        Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
        Nov 20 LLY More companies covering weight loss drugs for their employees
        Nov 20 LLY Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
        Nov 20 LLY China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
        Nov 20 LLY Eli Lilly Option Trade Produces $1,125, If You Can Tolerate The Heavy Risk
        Nov 20 LLY Is It Time to Sell Eli Lilly and Pfizer Stocks?
        Nov 20 LLY Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
        Nov 20 LLY The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley
        Nov 20 LLY RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
        Nov 19 LLY Lilly announces changes on board of directors
        Nov 19 LLY Top Research Reports for Eli Lilly, PepsiCo & Morgan Stanley
        Nov 19 LLY LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II Study
        Nov 19 LLY Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
        Nov 19 LLY Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%
        Nov 19 LLY Jim Cramer: Coinbase Is A 'Winner,' Suggests Buying This 'Hated' Big Pharma Stock
        Nov 19 LLY Here’s Why Eli Lilly and Company (LLY) is on Detractors’ List of Madison Sustainable Equity Fund
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes
        Percutaneous Coronary Intervention

        Percutaneous Coronary Intervention (PCI) is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. It involves inserting a catheter into a blood vessel in the arm or leg and guiding it to the narrowed or blocked coronary artery. A balloon is then inflated to widen the artery and a stent is inserted to keep it open. PCI can improve blood flow to the heart and reduce the risk of a heart attack.

        Browse All Tags